Clinical Pharmacist Interventions in Critically Ill Patients with COVID-19

被引：0
|
作者：
Hida, A. [1 ,2 ,3 ]
Faroudy, M. [1 ,2 ,4 ]
Cadi, M. A. E. [1 ,2 ,3 ]
Chaibi, A. [1 ,2 ,3 ]
机构：
[1] Mohamed V Souissi Univ, Fac Med, Rabat, Morocco
[2] Mohamed V Souissi Univ, Pharm Rabat, Rabat, Morocco
[3] Ibn Sina Univ Hosp, Dept Pharm, Rabat, Morocco
[4] Ibn Sina Univ Hosp, Intens Care Unit, Emergency Trauma Dept, Rabat, Morocco
来源：
DRUG SAFETY | 2022年 / 45卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P027
引用
收藏
页码：1141 / 1142
页数：2
相关论文
共 50 条
  • [21] Variants of concern and clinical outcomes in critically ill COVID-19 patients
    Intensive Care Medicine, 2023, 49 : 697 - 699
  • [22] Clinical Course of Critically Ill COVID-19 Patients with Tube Thoracostomy
    Rizer, Nicholas
    Mergler, Blake
    Smood, Benjamin
    Sperry, Alexandra
    Sertic, Federico
    Acker, Andrew
    Bermudez, Christian
    Gutsche, Jacob
    Usman, Asad A.
    ANESTHESIA AND ANALGESIA, 2021, 132 (5S_SUPPL): : 235 - 237
  • [23] Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19
    Vasquez, Charles R.
    Gupta, Shruti
    Miano, Todd A.
    Roche, Meaghan
    Hsu, Jesse
    Yang, Wei
    Holena, Daniel N.
    Reilly, John P.
    Schrauben, Sarah J.
    Leaf, David E.
    Shashaty, Michael G. S.
    CHEST, 2021, 160 (03) : 929 - 943
  • [24] Variants of concern and clinical outcomes in critically ill COVID-19 patients
    Kurtz, Pedro
    Bastos, Leonardo S. L. T.
    Ranzani, Otavio
    Soares, Marcio
    Zampieri, Fernando
    Hamacher, Silvio
    Salluh, Jorge A.
    Bozza, Fernando
    DP EFFECT BRAZIL investigators
    INTENSIVE CARE MEDICINE, 2023, 49 (06) : 697 - 699
  • [25] EVALUATION OF TOCILIZUMAB ON CLINICAL OUTCOMES IN CRITICALLY ILL PATIENTS WITH COVID-19
    Swartwood, Claire
    Miller, Christopher
    North, Michael
    Roshon, Michael
    Wedoff, Abigail
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 216 - 216
  • [26] Critically Ill Patients with COVID-19 and AKI: Clinical Characteristics and Outcomes
    El Mouhayyar, Christopher E.
    Dewald, Jonathan
    Cabrales, Jose
    Tighiouart, Hocine
    Moraco, Andrew H.
    Jaber, Bertrand L.
    Balakrishnan, Vaidyanathapuram
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 63 - 63
  • [27] COVID-19 and clinical pharmacist interventions-is there an impact?
    Rei, Maria
    Gomes, Ana P.
    Silva, Ana R.
    Pereira, Catia
    Luque, Jesus C.
    Fernandes, Laura
    Lemos, Rita
    Rodrigues, Rui
    Rosado, Nazare
    Pimenta, Miguel
    Capoulas, Miriam
    Santos, Claudia
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (06) : 1777 - 1777
  • [28] Nutritional Therapy for Critically Critically Ill COVID-19 Patients
    Ozer, Nurhayat Tugra
    Gundogan, Kursat
    JOURNAL OF CRITICAL & INTENSIVE CARE, 2020, 11 : 48 - 50
  • [29] Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients
    Leache, Leire
    Aquerreta, Irene
    Aldaz, Azucena
    Monedero, Pablo
    Idoate, Antonio
    Ortega, Ana
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (09): : 1285 - 1289
  • [30] Composite Interventions on Outcomes of Severely and Critically Ill Patients with COVID-19 in Shanghai, China
    Shao, Jiasheng
    Fan, Rong
    Guo, Chengnan
    Huang, Xuyuan
    Guo, Runsheng
    Zhang, Fengdi
    Hu, Jianrong
    Huang, Gang
    Cao, Liou
    MICROORGANISMS, 2023, 11 (07)
12345